Jacobs Levy Equity Management, Inc Tg Therapeutics, Inc. Transaction History

Jacobs Levy Equity Management, Inc

$24.7 Billion
Q3 2024

A detailed history of Jacobs Levy Equity Management, Inc transactions in Tg Therapeutics, Inc. stock. As of the latest transaction made, Jacobs Levy Equity Management, Inc holds 180,338 shares of TGTX stock, worth $5.21 Million. This represents 0.02% of its overall portfolio holdings.

Number of Shares

180,338

Previous 180,338 -0.0%

Holding current value

$5.21 Million

Previous $3.21 Million 31.48%

% of portfolio

0.02%

Previous 0.01%

15 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 14, 2024	SELL	$13.32 - $19.19 $4.59 Million - $6.61 Million	-344,523 Reduced 65.64%	180,338 $3.21 Million
Q1 2024 May 15, 2024	BUY	$13.02 - $21.3 $1.57 Million - $2.57 Million	120,699 Added 29.86%	524,861 $7.98 Million
Q4 2023 Feb 14, 2024	SELL	$6.68 - $18.81 $9,726 - $27,387	-1,456 Reduced 0.36%	404,162 $6.9 Million
Q3 2023 Nov 16, 2023	BUY	$8.36 - $26.5 $1.22 Million - $3.86 Million	145,667 Added 56.04%	405,618 $3.39 Million
Q1 2023 May 15, 2023	SELL	$10.23 - $19.34 $1.1 Million - $2.08 Million	-107,522 Reduced 29.26%	259,951 $3.91 Million
Q4 2022 Feb 14, 2023	BUY	$5.01 - $11.83 $1.28 Million - $3.02 Million	254,978 Added 226.66%	367,473 $4.35 Million
Q3 2022 Nov 15, 2022	BUY	$4.57 - $8.4 $514,102 - $944,958	112,495 New	112,495 $666,000
Q3 2020 Nov 16, 2020	SELL	$18.49 - $27.24 $441,910 - $651,036	-23,900 Closed	0 $0
Q2 2020 Aug 17, 2020	SELL	$8.9 - $21.84 $13,358 - $32,781	-1,501 Reduced 5.91%	23,900 $466,000
Q1 2020 May 15, 2020	SELL	$7.14 - $15.99 $1.03 Million - $2.3 Million	-143,799 Reduced 84.99%	25,401 $250,000
Q4 2019 Feb 14, 2020	BUY	$5.1 - $11.2 $248,879 - $546,560	48,800 Added 40.53%	169,200 $1.88 Million
Q3 2019 Nov 14, 2019	BUY	$5.38 - $8.99 $66,712 - $111,476	12,400 Added 11.48%	120,400 $676,000
Q2 2019 Aug 13, 2019	BUY	$6.27 - $8.65 $677,160 - $934,200	108,000 New	108,000 $934,000
Q3 2018 Nov 14, 2018	SELL	$5.15 - $14.0 $137,556 - $373,940	-26,710 Closed	0 $0
Q2 2018 Aug 14, 2018	BUY	$12.5 - $15.0 $333,875 - $400,650	26,710 New	26,710 $351,000

Others Institutions Holding TGTX

# of Institutions

337

Shares Held

87.7M

Call Options Held

2.35M

Put Options Held

1.7M

View Full List

About TG THERAPEUTICS, INC.

Ticker TGTX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 145,274,000
Market Cap $4.2B
Description
TG Therapeutics, Inc., a commercial stage biopharmaceutical company, focuses on the acquisition, development, and commercialization of novel treatments for B-cell malignancies and autoimmune diseases. Its therapeutic product candidates include Ublituximab, an investigational glycoengineered monoclonal antibody for the treatment of B-cell non-hod...

More about TGTX

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Jacobs Levy Equity Management, Inc, based on Form 13F filings with the SEC.

News

Stay updated on Jacobs Levy Equity Management, Inc with notifications on news.

Account

Jacobs Levy Equity Management, Inc Tg Therapeutics, Inc. Transaction History